FTSE All-Share

FTSE All-Share handeln
5.735,46 PKT +15,93 PKT +0,28 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
28.04.15 Standard Chartered Hold S&P Capital IQ
28.04.15 AstraZeneca buy UBS AG
28.04.15 GSK buy Goldman Sachs Group Inc.
27.04.15 Prudential buy Jefferies & Company Inc.
27.04.15 AstraZeneca Neutral Goldman Sachs Group Inc.
27.04.15 HSBC Conviction Buy List Goldman Sachs Group Inc.
24.04.15 AstraZeneca Hold S&P Capital IQ
24.04.15 Glencore Neutral Citigroup Corp.
24.04.15 Rio Tinto Neutral Citigroup Corp.
24.04.15 Sky buy Citigroup Corp.
23.04.15 Vodafone Group overweight JP Morgan Chase & Co.
23.04.15 Unilever Underweight JP Morgan Chase & Co.
23.04.15 Unilever Underweight JP Morgan Chase & Co.
23.04.15 Glencore Conviction Buy List Goldman Sachs Group Inc.
23.04.15 Vodafone Group buy Goldman Sachs Group Inc.
23.04.15 Unilever Neutral Goldman Sachs Group Inc.
23.04.15 HSBC Conviction Buy List Goldman Sachs Group Inc.
23.04.15 Shell (ex Royal Dutch Shell) Hold Deutsche Bank AG
23.04.15 BAT buy UBS AG
23.04.15 BP buy Deutsche Bank AG
23.04.15 HSBC Hold Deutsche Bank AG
23.04.15 Lloyds Banking Group buy Deutsche Bank AG
23.04.15 Barclays buy Deutsche Bank AG
23.04.15 Standard Chartered Sell Deutsche Bank AG
23.04.15 BP buy HSBC
23.04.15 Shell (ex Royal Dutch Shell) Hold HSBC
22.04.15 Rio Tinto Neutral UBS AG
22.04.15 Sky Neutral Nomura
22.04.15 Rio Tinto overweight JP Morgan Chase & Co.
22.04.15 BT Group buy Nomura
22.04.15 Sky Neutral Goldman Sachs Group Inc.
22.04.15 Standard Chartered verkaufen Credit Suisse Group
22.04.15 GSK Underweight JP Morgan Chase & Co.
22.04.15 Barclays buy Citigroup Corp.
21.04.15 Sky Hold S&P Capital IQ
21.04.15 Rio Tinto Hold S&P Capital IQ
21.04.15 Rio Tinto Equal-Weight Morgan Stanley
21.04.15 AstraZeneca Neutral JP Morgan Chase & Co.
21.04.15 Rio Tinto Neutral UBS AG
21.04.15 GSK market-perform Bernstein Research